Abstract
Recent rapid advances in the basic research into pemphigus have provided many insights into its pathophysiology. In particular, a recently developed enzyme-linked immunosorbent assay (ELISA) for desmogleins 1 and 3 (Dsg1 and Dsg3), antigens for pemphigus foliaceus (PF) and pemphigus vulgaris (PV), respectively, has led to great progress in the diagnosis and classification of pemphigus, as well as in understanding its pathomechanisms. Studies with the anti-Dsg1 and anti-Dsg3 antibodies have indicated that there are two types of PV, the mucosal dominant type and the mucocutaneous type. The same ELISA has identified the antigens in pemphigus herpetiformis. The autoantigens detected by this ELISA correlate well with the clinical features in pemphigus patients in showing the shift between PV and PF. In addition, the Dsg compensation theory proposed by Stanley and Amagai can reasonably explain the different depths of skin lesions and the different occurrences of skin and oral mucosal lesions between PV and PF. Furthermore, a complicated profile of autoantigens in paraneoplastic pemphigus (PNP) has been indicated in various biochemical studies, and IgG anti-Dsg1 and anti-Dsg3 antibodies have been detected in serum from all the PNP patients by the above ELISA. On the other hand, serum from subcorneal pustular dermatosis type IgA pemphigus patients have been shown to react with Dsc1, another type of desmosomal cadherin, by a novel cDNA transfection method. In addition, IgA anti-Dsg1 and anti-Dsg3 antibodies have been detected in a few patients with IgA pemphigus by an ELISA for IgA antibodies. Various autoimmune bullous diseases, including several types of pemphigus, are the only diseases in which the pathogenic role of circulating autoantibodies has been confirmed using the newborn mouse animal model. Therefore, studies of the pathophysiology of pemphigus are extremely important as a paradigm for research into various types of autoimmune diseases in other fields.
Similar content being viewed by others
References
Koch PJ, Franke WW (1994) Desmosomal cadherins: another growing multigene family of adhesion molecules. Curr Opin Cell Biol 6:682–687
Buxton RS, Cowin P, Franke WW, Garrod DR, Green KJ, King IA, Koch PJ, Magee AI, Rees DA, Stanley JR, Steinberg MS (1993) Nomenclature of the desmosomal cadherins. J Cell Biol 121:481–483
Amagai M (1995) Adhesion molecules: I: Keratinocyte-keratinocyte interactions; cadherins and pemphigus. J Invest Dermatol 104:146–152
Garrod D, Chidgey M, North A (1996) Desmosomes: differentiation, development, dynamics and disease. Curr Opin Cell Biol 8:670–678
Zillikens D (1999) Acquired skin disease of hemidesmosomes. J Dermatol Sci 20:122–133
Beutner EH, Jordon RE, Chorzelski TP (1968) The immunopathology of pemphigus and bullous pemphigoid. J Invest Dermatol 51:63–80
Robinson ND, Hashimoto T, Amagai M, Chan LS (1999) Continuing medical education: the new pemphigus variants. J Am Acad Dermatol 40:649–671
Hashimoto T (1999) Skin diseases related to abnormality in desmosomes and hemidesmosomes (editorial review); special issue of review articles in Journal of Dermatological Science. J Dermatol Sci 20:81–84
Koch PJ, Walsh MJ, Schmelz M, et al (1990) Identification of desmoglein, a constitutive desmosomal glycoprotein, as a member of the cadherin family of cell adhesion molecules. Eur J Cell Biol 53:1–12
Hashimoto T, Ogawa MM, Konohana A, Nishikawa T (1990) Detection of pemphigus vulgaris and pemphigus foliaceus antigens by immunoblot analysis using different antigen sources. J Invest Dermatol 94:327–331
Hashimoto T, Konohana A, Nishikawa T (1991) Immunoblot assay as an aid to the diagnoses of unclassified cases of pemphigus. Arch Dermatol 127:843–847
Amagai M, Klaus-Kovtun V, Stanley JR (1991) Autoantibodies against a novel epithelial cadherin in PV, a disease of cell adhesion. Cell 67:869–877
Hashimoto T, Amagai M, Garrod DR, et al (1995) Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1. Epithelial Cell Biol 4:63–69
Amagai M, Tsunoda K, Zillikens D, Nagai T, Nishikawa T (1999) The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol 40:167–170
Mahoney MG, Wang Z, Rothenberger K, Koch PJ, Amagai M, Stanley JR (1999) Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 103:461–468
Jablonska S, Chorzelski TP, Beutner EH, Chorzelska J (1975) Herpetiform pemphigus, a variable pattern of pemphigus. Int J Dermatol 14:353–359
Brenner S, Bialy-Golan A, Anhalt GJ (1997) Recognition of pemphigus antigens in drug-induced pemphigus vulgaris and pemphigus foliaceus. J Am Acad Dermatol 36:919–923
Kawana S, Hashimoto T, Nishikawa T, Nishiyama S (1994) Changes in clinical features, histologic findings, and antigen profiles with development of pemphigus foliaceus from pemphigus vulgaris. Arch Dermatol 130:1534–1538
Ishii K, Amagai M, Ohata Y, Shimizu H, Hashimoto T, Ohya K, Nishikawa T (2000) Development of pemphigus vulgaris in a patient with pemphigus foliaceus anti-desmoglein antibody profile shift by enzyme-linked immunosorbent assay. J Am Acad Dermatol 42:859–861
Anhalt GJ, Kim S-C, Stanley JR, Korman NJ, Jabs DA, Kory M, Izumi H, Ratrie H III, Mutasim D, Ariss-Abdo L, Labib RS (1990) An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 323:1729–1735
Anhalt GJ (1997) Paraneoplastic pemphigus. Adv Dermatol 12:77–96
Iwatsuki K, Hashimoto T, Ebihara T, Teraki Y, Nishikawa T, Kaneko F (1991) Intercellular IgA vesiculo-pustular dermatosis and related disorders: diversity of IgA anti-intercellular autoantibodies. Eur J Dermatol 3:7–11
Ebihara T, Hashimoto T, Iwatsuki K, Takigawa M, Ando M, Ohkawara A, Nishikawa T (1991) Autoantigens for IgA anti-intercellular antibodies of intercellular IgA vesiculopustular dermatosis. J Invest Dermatol 97:742–745
Hashimoto T (2001) Immunopathology of IgA pemphigus. Clin Dermatol 19:683–689
Prost C, Intrator L, Wechsler J (1991) IgA autoantibodies bind to pemphigus vulgaris antigen in a case of intraepidermal neutrophilic IgA dermatosis. J Am Acad Dermatol 25:846–848
Wang J, Kwon J, Ding X, Fairley JA, Woodley DT, Chan LS (1997) Nonsecretory IgA1 autoantibodies targeting desmosomal component desmoglein 3 in intraepidermal neutrophilic IgA dermatosis. Am J Pathol 150:1901–1907
Karpati S, Amagai M, Li LW, Dmochowski M, Hashimoto T, Horvath A (2000) Identification of desmoglein 1 as an autoantigen in a patient with intraepidermal neutrophilic IgA dermatosis type of IgA pemphigus. Exp Dermatol 9:224–228
Chorzelski TP, Hashimoto T, Nishikawa T (1994) Unusual acantholytic bullous dermatosis associated with neoplasia and antibodies of IgG and IgA classed against bovine desmocollins I and II. J Am Acad Dermatol 31:351–355
Miyagawa S, Hashimoto T, Ohno H, Nakagawa A, Watanabe K, Hashimoto T, Shirai T (1995) Atypical pemphigus associated with monoclonal IgA gammopathy. J Am Acad Dermatol 32:352–357
Ogawa MM, Hashimoto T, Nishikawa T, Castro RM (1989) IgG subclasses of intercellular antibodies in Brazilian pemphigus foliaceus—the relationship to complement fixing capability. Clin Exp Dermatol 14:29–31
Morini JP, Jomaa B, Gorgi Y, Saguem MH, Nouira R, Roujeau JC, et al (1993) Pemphigus foliaceus in young women. An endemic focus in the Sousse area of Tunisia. Arch Dermatol 129:69–73
Abreu AM, Maldonado JG, Jaramillo A, Patiño PJ, Prada S, Leon W, et al (1998) Immunological characterization of a unique focus of endemic pemphigus foliaceus in the rural area of El Bagre, Colombia (abstract). J Invest Dermatol 110:516
Anhalt GJ, Labib RS, Voorhees JJ, et al (1982) Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 306:1189–1196
Amagai M, Hashimoto T, Shimizu N, Nishikawa T (1994) Absorption of pathogenic autoantibodies by the extracellular domain of PV antigen (Dsg3) produced by baculovirus. J Clin Invest 94:59–67
Amagai M, Hashimoto T, Green K, Shimizu N, Nishikawa T (1995) Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J Invest Dermatol 104:895–901
Ishii K, Amagai M, Hall RP, Hashimoto T, Takayanagi A, Gamou S, Shimizu N, Nishikawa T (1997) Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol 159:2010–2017
Amagai M, Hashimoto T, Komai A, Hashimoto K, Kitajima Y, Ohya K, Iwanami H, Nishikawa T (1999) Usefulness of enzyme-linked immunosorbent assay (ELISA) using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br J Dermatol 140:351–357
Ishii K, Amagai M, Komai A, Ebihara T, Chorzelski TP, Ohya K, Nishikawa T, Hashimoto T (1999) Desmoglein 1 and desmoglein 3 are the target autoantigens in herpetiform pemphigus. Arch Dermatol 135:943–947
Komai A, Amagai M, Ishii K, Nishikawa T, Chorzelski T, Matsuo I, Hashimoto T (2001) The clinical transition between pemphigus foliaceus and pemphigus vulgaris correlates well with the changes in autoantibody profile assessed by an enzyme-linked immunosorbent assay. Br J Dermatol 144:1177–1182
Koch PJ, Mahoney MG, Ishikawa H, Pulkkinen L, Uitto J, Shultz L, Murphy GF, Whitaker-Menezes D, Stanley JR (1997) Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol 137:1091–1102
Singer KH, Sawka NJ, Samowitz HR, Lazarus GS (1980) Proteinase activation: a mechanism for cellular dyshesion in pemphigus. J Invest Dermatol 74:363–367
Hashimoto K, Shafran KM, Webber PS, Lazarus GS, Singer KH (1983) Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. J Exp Med 157:259–272
Aoyama Y, Owada MK, Kitajima Y (1999) A pathogenic autoantibody, pemphigus IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes. Eur J Immunol 29:2233–2240
Aoyama Y, Kitajima Y (1999) Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous cell carcinoma cell line, DJM-1 cells. J Invest Dermatol 112:67–71
Caldelari R, de Bruin A, Baumann D, Suter MM, Bierkamp C, Balmer V, Muller E (2001) A central role for the armadillo protein plakoglobin in the autoimmune disease pemphigus vulgaris. J Cell Biol 153:823–834
Amagai M, Tsunoda K, Suzuki H, Nishifuji K, Koyasu S, Nishikawa T (2000) Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus. J Clin Invest 105:625–631
Emmerson RW, Wilson-Jones E (1968) Eosinophilic spongiosis in pemphigus. Arch Dermatol 97:252–257
Kubo A, Amagai M, Hashimoto T, Doi T, Higashiyama M, Hashimoto K, Yoshikawa K (1997) A case of herpetiform pemphigus showing reactivity with pemphigus vulgaris antigen (desmoglein 3). Br J Dermatol 137:109–113
O'Toole EA, Mak LL, Guitart J, Woodley DT, Hashimoto T, Amagai M, Chan LS (2000) Induction of keratinocyte interleukin-8 expression and secretion by IgG autoantibodies as a novel mechanism of epidermal neutrophil recruitment in a pemphigus variant. Clin Exp Immunol 119:217–224
Chorzelski TP, Hashimoto T, Jablonska S, Nishikawa T, Kozlowska A, Krainska T, Osiecki M, Olszewska M, Rywik H (1995) Pemphigus vulgaris transforming into pemphigus foliaceus and their coexistence. Eur J Dermatol 5:386–390
Nishibori Y, Hashimoto T, Ishiko A, Shimizu H, Korman NJ, Nishikawa T (1995) Paraneoplastic pemphigus: the first report from Japan. Dermatology 191:39–42
Horn TD, Anhalt GJ (1992) Histologic features of paraneoplastic pemphigus. Arch Dermatol 128:1091–1095
Oursler JR, Labib RS, Ariss-Abdo L, Burke T, O'Keefe EJ, Anhalt GJ (1992) Human autoantibodies against desmoplakins in paraneoplastic pemphigus. J Clin Invest 89:1775–1782
Hashimoto T, Amagai M, Watanabe K, Chorzelski PT, Bhogal BS, Black MM, Stevens HP, Boosma DM, Korman NJ, Gamou S, Shimizu N, Nishikawa T (1995) Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol 104:829–834
Kiyokawa C, Ruhrberg C, Karashima T, Mori O, Nishikawa T, Green KJ, Anhalt GJ, Watt FM, Hashimoto T (1998) Envoplakin and periplakin are components of the paraneoplastic pemphigus antigen complex. J Invest Dermatol 111:1236–1238
Kim S-C, Kwon YD, Lee IJ, et al (1997) cDNA cloning of the 210 kDa paraneoplastic pemphigus antigen reveals that envoplakin is a component of the antigen complex. J Invest Dermatol 109:365–369
Mahoney MG, Aho S, Uitto J, Stanley JR (1998) The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin. J Invest Dermatol 111:308–313
Nagata Y, Karashima T, Watt FM, Salmhofer W, Kanzaki T, Hashimoto T (2001) Paraneoplastic pemphigus sera react strongly with multiple epitopes on the various regions of envoplakin and periplakin, except for C-terminal homologous domain of periplakin. J Invest Dermatol 116:556–563
Chan LS, Vanderlugt CJ, Cooper KD, Hashimoto T, Nishikawa T, Zone JJ, Black MM, Stevens SR, Yancey KB, Chen M, Fairley JA, Woodley DT, Miller SD, Gordon KB (1998) Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol 110:103–109
Hashimoto T, Amagai M, Wang N, Nishikawa N, Karashima T, Mori O, Jablonskac S, Chorzelski TP (1998) Novel non-radioisotope immunoprecipitation studies indicate involvement of pemphigus vulgaris antigen in paraneoplastic pemphigus. J Dermatol Sci 17:132–139
Amagai M, Nishikawa T, Anhalt GJ, Hashimoto T (1998) Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest 102:775–782
Nousari HC, Deterding R, Wojtczack H, Aho S, Uitto J, Hashimoto T, Anhalt GJ (1999) The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med 340:1406–1410
Foedinger D, Anhalt GJ, Boecskoer B, et al (1995) Autoantibodies to desmoplakin I and II in patients with erythema multiforme. J Exp Med 181:169–179
Yasuda H, Kobayashi H, Hashimoto T, Itoh K, Yamane M, Nakamura J (2000) Subcorneal pustular dermatosis type of IgA pemphigus: demonstration of autoantibodies to desmocollin-1 and clinical review. Br J Dermatol 143:144–148
Hashimoto T, Inamoto N, Nakamura K, Nishikawa T (1987) Intercellular IgA dermatosis with clinical features of subcorneal pustular dermatosis. Arch Dermatol 123:1062–1065
Tagami H, Iwatsuki K, Iwase Y, Yamada M (1983) Subcorneal pustular dermatosis with vesiculo-bullous eruption: demonstration of subcorneal IgA deposits and a leukocyte chemotactic factor. Br J Dermatol 109:581–587
Huff JC, Golitz LE, Kunke KS (1985) Intraepidermal neutrophilic IgA dermatosis. N Engl J Med 313:1643
Teraki Y, Amagai N, Hashimoto T, Kusunoki T, Nishikawa T (1991) Intercellular IgA dermatosis of childhood. selective deposition of monomer IgA1 in the intercellular space of the epidermis. Arch Dermatol 127:221–224
Inazumi T, Kikuchi A, Han-Yaku H, Hashimoto T, Nishikawa T (1997) Intercellular IgA vesiculopustular dermatosis: an additional case and a review of the literature. Eur J Dermatol 7:503–507
Hashimoto T, Kiyokawa C, Mori O, Miyasato M, Chidgey MAJ, Garrod DR, Kobayashi Y, Komori K, Ishii K, Amagai M, Nishikawa T (1997) Human desmocollin 1 (Dsc1) is an autoantigen for subcorneal pustular dermatosis type of IgA pemphigus. J Invest Dermatol 109:127–131
Hashimoto T, Komai A, Futei Y, Nishikawa T, Amagai M (2001) Desmogleins are targeted by IgA autoantibodies of a few IgA pemphigus patients. Arch Dermatol 137:735–738
Niizeki H, Inoko H, Narimatsu H, Takata H, Sonoda A, Tadakuma T, Ando A, Tsuji K, Hashimoto T, Nishikawa T (1991) HLA class II antigens are associated with Japanese pemphigus patients. Hum Immunol 31:246–250
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hashimoto, T. Recent advances in the study of the pathophysiology of pemphigus. Arch Dermatol Res 295 (Suppl 1), S2–S11 (2003). https://doi.org/10.1007/s00403-002-0366-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-002-0366-3